Biohaven reports positive patient data for autoimmune disease drugs

Go back to Biohaven reports positive patient data for autoimmune disease drugs
(NYSE: BHVN) Delayed: 15.24 +1.67 (12.31%)
Previous Close $13.57    52 Week High
Open $14.07    52 Week Low
Day High $15.65    P/E N/A 
Day Low $14.07    EPS
Volume 2,105,881